| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_878b6067354cc170926ebc5d3249566d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0242fb8288f55574d0e0c58f13cd952
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56560534bef2b97b29fe78b1d71326db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a3636582a5cd5e2868de6bdbafd4f0b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18559e79d76b67551e324631743310b0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L2-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H3-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
2007-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb755a18de6fd5750f8430f5644ad687
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_458611a989fa6ab053d8df6e16f1e874
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25c8ae1b83d9568409c3a40263668ca4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9decca885f1b31c45da12a9d1d0a6be |
| publicationDate |
2008-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008056452-A1 |
| titleOfInvention |
Utilization of rare sugar for slowing the onset or progress of mobility impairment relating to amyotrophic lateral sclerosis |
| abstract |
[PROBLEMS] To provide a drug or a food for specified health uses aiming at slowing the onset or progress of mobility impairment relating to amyotrophic lateral sclerosis. [MEANS FOR SOLVING PROBLEMS] An agent containing D-allose as the active ingredient and aiming at slowing the onset or progress of mobility impairment relating to amyotrophic lateral sclerosis. A composition in the form of a food, a drink or a drug which contains the agent for slowing the onset or progress as described above. The above-described composition wherein the daily dose of D-allose is from 0.5 to 50 g. A food or a drink containing D-allose as the active ingredient which is indicated as being used for slowing the onset or progress of mobility impairment relating to amyotrophic lateral sclerosis. A method of slowing the onset or progress of mobility impairment relating to amyotrophic lateral sclerosis in a human subject which comprises administering or feeding D-allose in an efficacious amount to the subject. A method of treating a human subject diagnosed as suffering from amyotrophic lateral sclerosis which comprises administering or feeding to the subject D-allose in an efficacious amount for slowing the progress of mobility impairment. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102836166-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2537422-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016065044-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021193659-A1 |
| priorityDate |
2006-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |